Before joining HGF in 2016, John worked for four years in the in-house attorney team of Rolls-Royce Plc, and for five years in private practice. Experienced in patent drafting and portfolio management, he is recognised for his high and cost-effective success rate in prosecution. He also has particular skills in clearance and opinion work, using tried and tested approaches whilst tailoring for budget, time-frame, scale and risk appetite.
John is a fully qualified Chartered and European Patent Attorney. He also holds a postgraduate degree in Management of Intellectual Property from Queen Mary University of London (which he passed with distinction) and an undergraduate degree in Physics from the University of Warwick, UK.
John is highly experienced in the field of gas turbine engine design, manufacture and operation. He has also practiced in technology fields including telecommunications, automotive components and systems, navigation systems, construction, medical devices, ablution systems, bar equipment and composites.
Having experienced a well developed mid-size in-house team and participated in the evolution of its management and administrative systems, John can assist with developing a client’s Intellectual Property management infrastructure. His in-house experience also means he is comfortable liaising with all business functions and in particular inventors and managers at all levels of seniority.
John strives to achieve an in-house department style experience for his clients, proactively working to fully understand their businesses and to improve their Intellectual Property understanding. The hallmark of this approach is the provision of clear and comprehensive advice suited to the client’s unique commercial circumstances.
Management of Intellectual Property
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
The UK musician, Ed Sheeran, one of the world’s best selling artists with sales of 26 million albums and 100 million singles worldwide, has successfully defended a claim brought against …Read article
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.